Editorial: Recent advances in the understanding of hepatocellular carcinogenesis.
作者信息
Banini Bubu A, Mehta Rohini, Santhekadur Prasanna K
机构信息
Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, United States.
Inova Health System, Falls Church, VA, United States.
出版信息
Front Oncol. 2022 Jul 20;12:963998. doi: 10.3389/fonc.2022.963998. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Recent advances in the understanding of hepatocellular carcinogenesis.社论：肝细胞癌发生机制研究的最新进展
Front Oncol. 2022 Jul 20;12:963998. doi: 10.3389/fonc.2022.963998. eCollection 2022.
2
Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC.Withaferin A作为肝癌中肝脏X受体-α的新型调节剂。
Front Oncol. 2021 Jan 29;10:628506. doi: 10.3389/fonc.2020.628506. eCollection 2020.
3
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
4
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.ALDH2 缺乏通过激活富含氧化 DNA 的细胞外囊泡中的致癌途径促进酒精相关性肝癌。
J Hepatol. 2019 Nov;71(5):1000-1011. doi: 10.1016/j.jhep.2019.06.018. Epub 2019 Jul 4.
5
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.肝细胞癌综述：流行病学、病因学与致癌机制
J Carcinog. 2017 May 29;16:1. doi: 10.4103/jcar.JCar_9_16. eCollection 2017.
6
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.用于研究非酒精性脂肪性肝炎衍生的肝细胞癌潜在机制的小鼠模型。
World J Gastroenterol. 2018 May 14;24(18):1989-1994. doi: 10.3748/wjg.v24.i18.1989.
7
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.非酒精性脂肪性肝病/非酒精性脂肪性肝炎与肝细胞癌。
Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014.
8
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.非酒精性脂肪性肝病中的肝细胞癌：环境与遗传因素的作用
World J Gastroenterol. 2014 Sep 28;20(36):12945-55. doi: 10.3748/wjg.v20.i36.12945.
9
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者适度饮酒的影响。
Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.
10
Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.肝脏X受体介导乙型肝炎病毒相关肝细胞癌中乙型肝炎病毒X蛋白诱导的脂肪生成。
Hepatology. 2009 Apr;49(4):1122-31. doi: 10.1002/hep.22740.
引用本文的文献
1
Liver X Receptors (LXRs) in cancer-an Eagle's view on molecular insights and therapeutic opportunities.癌症中的肝脏X受体（LXRs）——关于分子见解和治疗机会的全景视角
Front Cell Dev Biol. 2024 Mar 14;12:1386102. doi: 10.3389/fcell.2024.1386102. eCollection 2024.
本文引用的文献
1
Is circulating exosome carry Staphylococcal nuclease domain-containing protein 1, a component of RNA-induced silencing complex?循环外泌体是否携带含葡萄球菌核酸酶结构域蛋白1，一种RNA诱导沉默复合体的组分？
Genes Dis. 2020 May 15;8(2):115-116. doi: 10.1016/j.gendis.2020.03.007. eCollection 2021 Mar.
2
Extracellular Vesicles as Inflammatory Drivers in NAFLD.细胞外囊泡作为 NAFLD 的炎症驱动因素。
Front Immunol. 2021 Feb 2;11:627424. doi: 10.3389/fimmu.2020.627424. eCollection 2020.
3
RISC assembly and post-transcriptional gene regulation in Hepatocellular Carcinoma.肝细胞癌中的RISC组装与转录后基因调控
Genes Dis. 2019 Sep 17;7(2):199-204. doi: 10.1016/j.gendis.2019.09.009. eCollection 2020 Jun.
4
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
5
Is Withaferin A, a magic bullet for metabolic syndrome?Withaferin A是治疗代谢综合征的神奇药物吗？
Biomed Pharmacother. 2017 Aug;92:1135-1137. doi: 10.1016/j.biopha.2017.04.002. Epub 2017 Apr 14.
6
Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling.富含 S 期核抗原结合蛋白 1 结构域的核酸酶 1（SND1）通过血管紧张素 II 型 1 受体（AT1R）和 TGFβ 信号促进迁移和侵袭。
FEBS Open Bio. 2014 Apr 1;4:353-61. doi: 10.1016/j.fob.2014.03.012. eCollection 2014.
7
Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.多功能蛋白含核酶结构域蛋白 1（SND1）通过涉及核因子 κB 和 miR-221 的新途径促进人肝癌血管生成。
J Biol Chem. 2012 Apr 20;287(17):13952-8. doi: 10.1074/jbc.M111.321646. Epub 2012 Mar 6.
8
Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).晚期 SV40 因子 (LSF) 通过转录上调基质金属蛋白酶-9 (MMP-9) 促进血管生成。
J Biol Chem. 2012 Jan 27;287(5):3425-32. doi: 10.1074/jbc.M111.298976. Epub 2011 Dec 13.
9
Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.RNA 诱导沉默复合物 (RISC) 活性增加与肝细胞癌有关。
Hepatology. 2011 May;53(5):1538-48. doi: 10.1002/hep.24216.
Zotero 插件